Cannizzaro D, Brinjikji W, Rammos S, Murad M H, Lanzino G
From the Departments of Neurosurgery (D.C., G.L.).
Radiology (W.B.)
AJNR Am J Neuroradiol. 2015 Oct;36(10):1905-11. doi: 10.3174/ajnr.A4394. Epub 2015 Aug 27.
Tentorial dural arteriovenous fistulas are characterized by a high hemorrhagic risk. We evaluated trends in outcomes and management of tentorial dural arteriovenous fistulas and performed a meta-analysis evaluating clinical and angiographic outcomes by treatment technique.
We performed a comprehensive literature search for studies on surgical and endovascular treatment of tentorial dural arteriovenous fistulas. We compared the proportion of patients undergoing endovascular, surgical, and combined endovascular/surgical management; the proportion of patients presenting with ruptured tentorial dural arteriovenous fistulas; and proportion of patients with good neurologic outcome across 3 time periods: 1980-1995, 1996-2005, and 2006-2014. We performed a random-effects meta-analysis, evaluating the rates of occlusion, long-term good neurologic outcome, perioperative morbidity, and resolution of symptoms for the 3 treatment modalities.
Twenty-nine studies with 274 patients were included. The proportion of patients treated with surgical treatment alone decreased from 38.7% to 20.4% between 1980-1995 and 2006-2014. The proportion of patients treated with endovascular therapy alone increased from 16.1% to 48.0%. The proportion of patients presenting with ruptured tentorial dural arteriovenous fistulas decreased from 64.4% to 43.6%. The rate of good neurologic outcome increased from 80.7% to 92.9%. Complete occlusion rates were highest for patients receiving multimodality treatment (84.0%; 95% CI, 72.0%-91.0%) and lowest for endovascular treatment (71.0%; 95% CI, 56.0%-83.0%; P < .01). Long-term good neurologic outcome was highest in the endovascular group (89.0%; 95% CI, 80.0%-95.0%) and lowest for the surgical group (73.0%; 95% CI, 51.0%-87.0%; P = .03).
Patients with tentorial dural arteriovenous fistulas are increasingly presenting with unruptured lesions, being treated endovascularly, and experiencing higher rates of good neurologic outcomes. Endovascular treatment was associated with superior neurologic outcomes but lower occlusion rates.
小脑幕硬脑膜动静脉瘘的特点是出血风险高。我们评估了小脑幕硬脑膜动静脉瘘的治疗结局和管理趋势,并进行了一项荟萃分析,以评估不同治疗技术的临床和血管造影结局。
我们对小脑幕硬脑膜动静脉瘘的手术和血管内治疗研究进行了全面的文献检索。我们比较了接受血管内、手术及血管内/手术联合治疗的患者比例;出现破裂小脑幕硬脑膜动静脉瘘的患者比例;以及在三个时间段(1980 - 1995年、1996 - 2005年和2006 - 2014年)神经功能结局良好的患者比例。我们进行了随机效应荟萃分析,评估了三种治疗方式的闭塞率、长期神经功能良好结局率、围手术期发病率及症状缓解情况。
纳入了29项研究,共274例患者。1980 - 1995年至2006 - 2014年间,单纯接受手术治疗的患者比例从38.7%降至20.4%。单纯接受血管内治疗的患者比例从16.1%增至48.0%。出现破裂小脑幕硬脑膜动静脉瘘的患者比例从64.4%降至43.6%。神经功能良好结局率从80.7%增至92.9%。接受多模式治疗的患者完全闭塞率最高(84.0%;95%可信区间,72.0% - 91.0%),血管内治疗的完全闭塞率最低(71.0%;95%可信区间,56.0% - 83.0%;P <.01)。血管内治疗组长期神经功能良好结局率最高(89.0%;95%可信区间,80.0% - 95.0%),手术组最低(73.0%;95%可信区间,51.0% - 87.0%;P =.03)。
小脑幕硬脑膜动静脉瘘患者中,未破裂病变的比例越来越高,越来越多地接受血管内治疗,且神经功能良好结局率更高。血管内治疗与更好的神经功能结局相关,但闭塞率较低。